Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection

Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O'Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret Olsen, Carey Ann D. Burnham, Hilary M. Babcock, Jennie Kwon

Research output: Contribution to journalArticlepeer-review

Abstract

In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.

Original languageEnglish
Article numbere93
JournalAntimicrobial Stewardship and Healthcare Epidemiology
Volume2
Issue number1
DOIs
StatePublished - Jun 15 2022

Fingerprint

Dive into the research topics of 'Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection'. Together they form a unique fingerprint.

Cite this